US4946786A
(en)
*
|
1987-01-14 |
1990-08-07 |
President And Fellows Of Harvard College |
T7 DNA polymerase
|
US4921794A
(en)
*
|
1987-01-14 |
1990-05-01 |
President And Fellows Of Harvard College |
T7 DNA polymerase
|
US4942130A
(en)
*
|
1987-01-14 |
1990-07-17 |
President & Fellows Of Harvard College |
T7 DNA polymerase
|
US5145776A
(en)
*
|
1987-01-14 |
1992-09-08 |
President & Fellows Of Harvard College |
Method of using T7 DNA polymerase to mutagenize and fill-in DNA
|
US5266466A
(en)
*
|
1987-01-14 |
1993-11-30 |
President And Fellows Of Harvard College |
Method of using T7 DNA polymerase to label the 3' end of a DNA molecule
|
US4994372A
(en)
*
|
1987-01-14 |
1991-02-19 |
President And Fellows Of Harvard College |
DNA sequencing
|
JP2634208B2
(ja)
*
|
1987-11-13 |
1997-07-23 |
パイオニア・ハイ―ブレツド・インターナシヨナル・インコーポレイテツド |
制限断片長多型性分析方法及びその装置
|
US5244797B1
(en)
*
|
1988-01-13 |
1998-08-25 |
Life Technologies Inc |
Cloned genes encoding reverse transcriptase lacking rnase h activity
|
US4962020A
(en)
*
|
1988-07-12 |
1990-10-09 |
President And Fellows Of Harvard College |
DNA sequencing
|
US5498523A
(en)
*
|
1988-07-12 |
1996-03-12 |
President And Fellows Of Harvard College |
DNA sequencing with pyrophosphatase
|
US5075216A
(en)
*
|
1988-09-23 |
1991-12-24 |
Cetus Corporation |
Methods for dna sequencing with thermus aquaticus dna polymerase
|
US5142033A
(en)
*
|
1988-09-23 |
1992-08-25 |
Hoffmann-La Roche Inc. |
Structure-independent DNA amplification by the polymerase chain reaction
|
US5091310A
(en)
*
|
1988-09-23 |
1992-02-25 |
Cetus Corporation |
Structure-independent dna amplification by the polymerase chain reaction
|
JPH0630640B2
(ja)
*
|
1989-02-06 |
1994-04-27 |
イーストマン コダック カンパニー |
熱安定性ポリメラーゼdnaシーケエンシング反応濃厚物
|
US5198543A
(en)
*
|
1989-03-24 |
1993-03-30 |
Consejo Superior Investigaciones Cientificas |
PHI29 DNA polymerase
|
US5001050A
(en)
*
|
1989-03-24 |
1991-03-19 |
Consejo Superior Investigaciones Cientificas |
PHφ29 DNA polymerase
|
US5045450A
(en)
*
|
1989-07-13 |
1991-09-03 |
Massachusetts Institute Of Technology |
Determination of a mutational spectrum
|
US5541099A
(en)
*
|
1989-08-10 |
1996-07-30 |
Life Technologies, Inc. |
Cloning and expression of T5 DNA polymerase reduced in 3'-to-5' exonuclease activity
|
US5047342A
(en)
*
|
1989-08-10 |
1991-09-10 |
Life Technologies, Inc. |
Cloning and expression of T5 DNA polymerase
|
US5270179A
(en)
*
|
1989-08-10 |
1993-12-14 |
Life Technologies, Inc. |
Cloning and expression of T5 DNA polymerase reduced in 3'- to-5' exonuclease activity
|
FR2650840B1
(fr)
*
|
1989-08-11 |
1991-11-29 |
Bertin & Cie |
Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications
|
DE4214112A1
(de)
*
|
1991-08-02 |
1993-02-04 |
Europ Lab Molekularbiolog |
Neues verfahren zur sequenzierung von nukleinsaeuren
|
US5674679A
(en)
*
|
1991-09-27 |
1997-10-07 |
Amersham Life Science, Inc. |
DNA cycle sequencing
|
US5756285A
(en)
*
|
1991-09-27 |
1998-05-26 |
Amersham Life Science, Inc. |
DNA cycle sequencing
|
US5869282A
(en)
|
1991-12-11 |
1999-02-09 |
Imperial Cancer Research Technology, Ltd. |
Nucleotide and protein sequences of the serrate gene and methods based thereon
|
US5830642A
(en)
*
|
1992-04-03 |
1998-11-03 |
Amersham Life Science, Inc. |
Electrophoresis of nucleic acid fragments
|
US5314595A
(en)
*
|
1992-04-03 |
1994-05-24 |
United States Biochemical Corporation |
Electrophoresis of nucleic acid fragments
|
US5401632A
(en)
*
|
1992-07-16 |
1995-03-28 |
Wisconsin Alumni Research Foundation |
Triple helix purification and sequencing
|
WO1994009154A1
(en)
*
|
1992-10-13 |
1994-04-28 |
United States Biochemical Corporation |
Stop solution
|
WO1994018218A1
(en)
*
|
1993-02-01 |
1994-08-18 |
Seq, Ltd. |
Methods and apparatus for dna sequencing
|
US6410277B1
(en)
*
|
1993-02-19 |
2002-06-25 |
Takara Shuzo Co., Ltd. |
DNA polymersases with enhanced length of primer extension
|
US7465539B1
(en)
|
1993-02-19 |
2008-12-16 |
Takara Bio, Inc. |
DNA polymerases with enhanced length of primer extension
|
US5436149A
(en)
*
|
1993-02-19 |
1995-07-25 |
Barnes; Wayne M. |
Thermostable DNA polymerase with enhanced thermostability and enhanced length and efficiency of primer extension
|
AU6418294A
(en)
*
|
1993-03-30 |
1994-10-24 |
United States Biochemical Corporation |
Use of exonuclease in dna sequencing
|
US5500339A
(en)
*
|
1993-03-30 |
1996-03-19 |
Amersham Life Science, Inc. |
DNA denaturation method
|
US7312052B1
(en)
*
|
1993-12-08 |
2007-12-25 |
Stratagene California |
Polymerase compositions and uses thereof
|
US6335160B1
(en)
*
|
1995-02-17 |
2002-01-01 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
US6406855B1
(en)
|
1994-02-17 |
2002-06-18 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
USH1531H
(en)
*
|
1994-04-18 |
1996-05-07 |
Blumentals; Ilse I. |
Thermophilic DNA polymerase
|
US5912155A
(en)
*
|
1994-09-30 |
1999-06-15 |
Life Technologies, Inc. |
Cloned DNA polymerases from Thermotoga neapolitana
|
US6015668A
(en)
*
|
1994-09-30 |
2000-01-18 |
Life Technologies, Inc. |
Cloned DNA polymerases from thermotoga and mutants thereof
|
US5614365A
(en)
*
|
1994-10-17 |
1997-03-25 |
President & Fellow Of Harvard College |
DNA polymerase having modified nucleotide binding site for DNA sequencing
|
US5545539A
(en)
*
|
1994-10-18 |
1996-08-13 |
Genzyme Corporation |
Method for nucleotide sequence amplification
|
NZ296748A
(en)
|
1994-11-02 |
1999-11-29 |
Univ New York State Res Found |
Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
|
IL114615A0
(en)
|
1995-07-16 |
1995-11-27 |
Yeda Res & Dev |
Modulators of the function of fas receptors and other proteins
|
CA2222744C
(en)
*
|
1995-05-31 |
2008-03-25 |
Amersham Life Science, Inc. |
Thermostable dna polymerases
|
ATE442373T1
(de)
|
1995-06-28 |
2009-09-15 |
Imp Cancer Res Tech |
Nukleotid- und proteinsequenzen von delta-genen von vertebraten und darauf basierende methoden
|
US5830657A
(en)
*
|
1996-05-01 |
1998-11-03 |
Visible Genetics Inc. |
Method for single-tube sequencing of nucleic acid polymers
|
US5888736A
(en)
*
|
1995-12-22 |
1999-03-30 |
Visible Genetics, Inc. |
Method, compositions and kit for detection and identification of microorganisms
|
US5789168A
(en)
*
|
1996-05-01 |
1998-08-04 |
Visible Genetics Inc. |
Method for amplification and sequencing of nucleic acid polymers
|
US5972603A
(en)
*
|
1996-02-09 |
1999-10-26 |
President And Fellows Of Harvard College |
DNA polymerase with modified processivity
|
US6214555B1
(en)
|
1996-05-01 |
2001-04-10 |
Visible Genetics Inc. |
Method compositions and kit for detection
|
US6083699A
(en)
*
|
1996-05-01 |
2000-07-04 |
Visible Genetics Inc. |
Method for bi-directional sequencing of nucleic acid polymers
|
US6413718B1
(en)
|
1996-05-01 |
2002-07-02 |
Visible Genetics Inc. |
Method for sequencing of nucleic acid polymers
|
AU4065397A
(en)
|
1996-08-14 |
1998-03-06 |
Life Technologies, Inc. |
Stable compositions for nucleic acid amplification and sequencing
|
US6291164B1
(en)
|
1996-11-22 |
2001-09-18 |
Invitrogen Corporation |
Methods for preventing inhibition of nucleic acid synthesis by pyrophosphate
|
US6306588B1
(en)
*
|
1997-02-07 |
2001-10-23 |
Invitrogen Corporation |
Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof
|
AU743025B2
(en)
|
1997-03-12 |
2002-01-17 |
Applera Corporation |
DNA polymerases having improved labeled nucleotide incorporation properties
|
WO1998042860A1
(en)
|
1997-03-21 |
1998-10-01 |
Stratagene |
Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying
|
WO1999010366A1
(en)
|
1997-08-29 |
1999-03-04 |
Life Technologies, Inc. |
High fidelity polymerases and uses thereof
|
CA2307016A1
(en)
*
|
1997-10-24 |
1999-05-06 |
Life Technologies, Inc. |
Recombinational cloning using nucleic acids having recombination sites
|
US6057106A
(en)
*
|
1998-01-23 |
2000-05-02 |
Novex |
Sample buffer and methods for high resolution gel electrophoresis of denatured nucleic acids
|
US6787305B1
(en)
|
1998-03-13 |
2004-09-07 |
Invitrogen Corporation |
Compositions and methods for enhanced synthesis of nucleic acid molecules
|
WO2000055169A1
(en)
*
|
1999-03-15 |
2000-09-21 |
Thomas Jefferson University |
TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS
|
US6630333B1
(en)
*
|
1999-03-23 |
2003-10-07 |
Invitrogen Corporation |
Substantially pure reverse transriptases and methods of production thereof
|
JP2002543795A
(ja)
*
|
1999-05-12 |
2002-12-24 |
インビトロゲン・コーポレーション |
核酸合成の感度および特異性の増大のための組成物および方法
|
US7056661B2
(en)
*
|
1999-05-19 |
2006-06-06 |
Cornell Research Foundation, Inc. |
Method for sequencing nucleic acid molecules
|
US7192729B2
(en)
|
1999-07-06 |
2007-03-20 |
General Atomics |
Methods for assaying homocysteine
|
US6376210B1
(en)
|
1999-07-06 |
2002-04-23 |
General Atomics |
Methods and compositions for assaying analytes
|
AU2001227679A1
(en)
*
|
2000-02-25 |
2001-09-03 |
General Atomics |
Mutant nucleic binding enzymes and use thereof in diagnostic, detection and purification methods
|
US6610504B1
(en)
|
2000-04-10 |
2003-08-26 |
General Atomics |
Methods of determining SAM-dependent methyltransferase activity using a mutant SAH hydrolase
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
US7198924B2
(en)
|
2000-12-11 |
2007-04-03 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
EP1317464B1
(en)
*
|
2000-10-11 |
2009-05-13 |
Applera Corporation |
Fluorescent nucleobase conjugates having anionic linkers
|
WO2002086088A2
(en)
*
|
2001-04-24 |
2002-10-31 |
Li-Cor, Inc. |
Polymerases with charge-switch activity and methods of generating such polymerases
|
US7238798B2
(en)
|
2001-08-14 |
2007-07-03 |
Sentisearch, Inc. |
Nucleic acids and proteins of insect Or83b odorant receptor genes and uses thereof
|
US7256019B2
(en)
*
|
2001-08-29 |
2007-08-14 |
Ge Healthcare Bio-Sciences Corp. |
Terminal phosphate blocked nucleoside polyphosphates
|
US20050042629A1
(en)
|
2002-09-13 |
2005-02-24 |
Applera Corporation |
Thermus scotoductus nucleic acid polymerases
|
WO2003025132A2
(en)
*
|
2001-09-14 |
2003-03-27 |
Invitrogen Corporation |
Dna polymerases and mutants thereof
|
JP2007528691A
(ja)
|
2001-11-14 |
2007-10-18 |
セントカー・インコーポレーテツド |
抗il−6抗体、組成物、方法および使用
|
US7222059B2
(en)
*
|
2001-11-15 |
2007-05-22 |
Siemens Medical Solutions Diagnostics |
Electrophoretic trace simulator
|
WO2003048308A2
(en)
|
2001-11-30 |
2003-06-12 |
Applera Corporation |
Thermus brockianus nucleic acid polymerases
|
WO2003068991A1
(en)
*
|
2002-02-12 |
2003-08-21 |
Applera Corporation |
Polymerase compositions
|
WO2004009768A2
(en)
*
|
2002-07-18 |
2004-01-29 |
Invitrogen Corporation |
Viral vectors containing recombination sites
|
CA2519309A1
(en)
|
2003-03-25 |
2004-10-14 |
Stratagene California |
Dna polymerase fusions and uses thereof
|
US9708410B2
(en)
|
2003-05-30 |
2017-07-18 |
Janssen Biotech, Inc. |
Anti-tissue factor antibodies and compositions
|
ATE469984T1
(de)
*
|
2003-12-01 |
2010-06-15 |
Life Technologies Corp |
Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
|
WO2006028496A2
(en)
*
|
2004-02-20 |
2006-03-16 |
Applera Corporation |
Lesion repair polymerase compositions
|
US7384760B2
(en)
*
|
2004-04-30 |
2008-06-10 |
General Atomics |
Methods for assaying inhibitors of S-adenosylhomocysteine (SAH) hydrolase and S-adenosylmethionine (SAM)-dependent methyltransferase
|
US20050282155A1
(en)
*
|
2004-06-17 |
2005-12-22 |
Lucigen Corporation |
Viral libraries from uncultivated viruses and polypeptides produced therefrom
|
PE20061324A1
(es)
|
2005-04-29 |
2007-01-15 |
Centocor Inc |
Anticuerpos anti-il-6, composiciones, metodos y usos
|
US20060292578A1
(en)
|
2005-06-28 |
2006-12-28 |
Weidong Zheng |
DNA polymerase blends and mutant DNA polymerases
|
TR201902033T4
(tr)
|
2005-06-30 |
2019-03-21 |
Janssen Biotech Inc |
Anti-IL-23 antikorları, bileşimleri, yöntemleri ve kullanımları.
|
US8093030B2
(en)
*
|
2005-10-06 |
2012-01-10 |
Lucigen Corporation |
Thermostable viral polymerases and methods of use
|
MX2008008621A
(es)
|
2005-12-29 |
2008-11-27 |
Centocor Inc |
Anticuerpos anti-il-23 humanos, composiciones, metodos y usos.
|
US20080118914A1
(en)
*
|
2006-01-04 |
2008-05-22 |
Charlotte Dawn Blowe |
Follistatin gene as a genetic marker for first parity litter size in pigs
|
US20070186298A1
(en)
*
|
2006-01-04 |
2007-08-09 |
Blowe Charlotte D |
Follistatin gene as a genetic marker for reproductive and performance traits in pigs
|
NZ590816A
(en)
|
2008-08-14 |
2013-02-22 |
Cephalon Australia Pty Ltd |
Anti-il-12/il-23 antibodies
|
PL2356269T3
(pl)
|
2008-10-31 |
2016-12-30 |
|
Kompozycje białek rusztowania oparte na domenie fibronektyny typu III, sposoby i zastosowania
|
CN102596992B
(zh)
|
2009-02-12 |
2015-09-09 |
詹森生物科技公司 |
基于ⅲ型纤连蛋白结构域的支架组合物、方法及用途
|
EA031203B1
(ru)
|
2010-03-30 |
2018-11-30 |
Янссен Байотек Инк. |
Гуманизированные антитела к il-25
|
AU2011352207B2
(en)
|
2010-12-31 |
2016-03-03 |
Bioatla, Llc |
Comprehensive monoclonal antibody generation
|
AU2011352205B2
(en)
|
2010-12-31 |
2016-06-16 |
Bioatla, Llc |
Express humanization of antibodies
|
EP2895620B1
(en)
|
2012-09-11 |
2017-08-02 |
Life Technologies Corporation |
Nucleic acid amplification
|
WO2014043143A1
(en)
|
2012-09-11 |
2014-03-20 |
Life Technologies Corporation |
Nucleic acid amplification
|
US9816088B2
(en)
|
2013-03-15 |
2017-11-14 |
Abvitro Llc |
Single cell bar-coding for antibody discovery
|
US10364458B2
(en)
|
2014-07-16 |
2019-07-30 |
Tangen Biosciences, Inc. |
Isothermal methods for amplifying nucleic acid samples
|
EP3194593B1
(en)
|
2014-09-15 |
2019-02-06 |
AbVitro LLC |
High-throughput nucleotide library sequencing
|
US11559801B2
(en)
|
2014-11-03 |
2023-01-24 |
Tangen Biosciences, Inc. |
Apparatus and method for cell, spore, or virus capture and disruption
|
EP3436477A2
(en)
|
2016-03-29 |
2019-02-06 |
Janssen Biotech, Inc. |
Method of treating psoriasis with increased interval dosing of anti-il12 and/or -23 antibody
|
MX2019000641A
(es)
|
2016-07-15 |
2019-06-10 |
Poseida Therapeutics Inc |
Composiciones de mucina1-receptor de antigeno quimerico y metodos para su uso.
|
JP2019524721A
(ja)
|
2016-07-15 |
2019-09-05 |
ポセイダ セラピューティクス, インコーポレイテッド |
キメラ抗原受容体および使用方法
|
EP3519049A4
(en)
|
2016-09-30 |
2020-05-27 |
Janssen Biotech, Inc. |
SAFE AND EFFICIENT METHOD FOR TREATING PSORIASIS WITH ANTI-IL23-SPECIFIC ANTIBODY
|
KR102447083B1
(ko)
|
2016-10-06 |
2022-09-26 |
포세이다 테라퓨틱스, 인크. |
유도성 카스파제 및 사용 방법
|
WO2018093841A1
(en)
|
2016-11-16 |
2018-05-24 |
Janssen Biotech, Inc. |
Method of treating psoriasis with anti-il-23 specific antibody
|
CN110234351A
(zh)
|
2017-01-30 |
2019-09-13 |
詹森生物科技公司 |
用于治疗活动性银屑病关节炎的抗tnf抗体、组合物和方法
|
CN110418652A
(zh)
|
2017-02-07 |
2019-11-05 |
詹森生物科技公司 |
用于治疗活动性强直性脊柱炎的抗tnf抗体、组合物和方法
|
AU2018235756A1
(en)
|
2017-03-13 |
2019-10-10 |
Poseida Therapeutics, Inc. |
Compositions and methods for selective elimination and replacement of hematopoietic stem cells
|
ES2926722T3
(es)
|
2017-05-26 |
2022-10-27 |
Abvitro Llc |
Secuenciación de alto rendimiento de biblioteca de polinucleótidos y análisis de transcriptoma
|
EP3645711A4
(en)
|
2017-06-30 |
2021-04-21 |
Codexis, Inc. |
T7 RNA POLYMERASE VARIANTS
|
JP2020530267A
(ja)
|
2017-06-30 |
2020-10-22 |
コデクシス, インコーポレイテッド |
T7 rnaポリメラーゼバリアント
|
WO2019051335A1
(en)
|
2017-09-07 |
2019-03-14 |
Juno Therapeutics, Inc. |
METHODS OF IDENTIFYING CELLULAR CHARACTERISTICS RELATED TO RESPONSES ASSOCIATED WITH CELL THERAPY
|
CA3072777A1
(en)
|
2017-09-08 |
2019-03-14 |
Poseida Therapeutics, Inc. |
Compositions and methods for chimeric ligand receptor (clr)-mediated conditional gene expression
|
TW201922780A
(zh)
|
2017-09-25 |
2019-06-16 |
美商健生生物科技公司 |
以抗il12/il23抗體治療狼瘡之安全且有效之方法
|
KR20200116917A
(ko)
|
2017-12-20 |
2020-10-13 |
포세이다 테라퓨틱스, 인크. |
Vcar 조성물 및 사용 방법
|
KR20200129125A
(ko)
|
2018-03-05 |
2020-11-17 |
얀센 바이오테크 인코포레이티드 |
항-il23 특이적 항체로 크론병을 치료하는 방법
|
TW202017592A
(zh)
|
2018-03-07 |
2020-05-16 |
美商波西達治療公司 |
CARTyrin組成物和使用方法
|
JP2021530697A
(ja)
|
2018-07-18 |
2021-11-11 |
ヤンセン バイオテツク,インコーポレーテツド |
抗il23特異的抗体で治療した後の持続応答予測因子
|
US20220389077A1
(en)
|
2018-09-05 |
2022-12-08 |
Poseida Therapeutics, Inc. |
Allogeneic cell compositions and methods of use
|
MA55149A
(fr)
|
2018-11-20 |
2021-09-29 |
Janssen Biotech Inc |
Procédé sûr et efficace de traitement du psoriasis avec un anticorps spécifique anti-il-23
|
US20200197517A1
(en)
|
2018-12-18 |
2020-06-25 |
Janssen Biotech, Inc. |
Safe and Effective Method of Treating Lupus with Anti-IL12/IL23 Antibody
|
WO2020132396A1
(en)
|
2018-12-20 |
2020-06-25 |
Poseida Therapeutics, Inc. |
Nanotransposon compositions and methods of use
|
JP2022518208A
(ja)
|
2019-01-15 |
2022-03-14 |
ヤンセン バイオテツク,インコーポレーテツド |
若年性特発性関節炎の治療のための抗tnf抗体、組成物、及び方法
|
WO2020152544A1
(en)
|
2019-01-23 |
2020-07-30 |
Janssen Biotech, Inc. |
Anti-tnf antibody compositions for use in methods for the treatment of psoriatic arthritis
|
CN113825765A
(zh)
|
2019-03-14 |
2021-12-21 |
詹森生物科技公司 |
用于制备抗il12/il23抗体组合物的制造方法
|
CA3133388A1
(en)
|
2019-03-14 |
2020-09-17 |
Janssen Biotech, Inc. |
Methods for producing anti-tnf antibody compositions
|
MA55283A
(fr)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech Inc |
Procédés de production de compositions d'anticorps anti-tnf
|
KR20210142002A
(ko)
|
2019-03-14 |
2021-11-23 |
얀센 바이오테크 인코포레이티드 |
항-tnf 항체 조성물을 생성하기 위한 제조 방법
|
US11780911B2
(en)
|
2019-05-23 |
2023-10-10 |
Janssen Biotech, Inc. |
Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha
|
CN113939531A
(zh)
|
2019-06-03 |
2022-01-14 |
詹森生物科技公司 |
用于治疗银屑病关节炎的抗tnf抗体组合物和方法
|
MX2021014882A
(es)
|
2019-06-03 |
2022-03-25 |
Janssen Biotech Inc |
Anticuerpos anti-tnf, composiciones y métodos para el tratamiento de la espondilitis anquilosante activa.
|
WO2021028752A1
(en)
|
2019-08-15 |
2021-02-18 |
Janssen Biotech, Inc. |
Anti-tfn antibodies for treating type i diabetes
|
US20220372105A1
(en)
|
2019-09-05 |
2022-11-24 |
Poseida Therapeutics, Inc. |
Allogeneic cell compositions and methods of use
|
KR20220117915A
(ko)
|
2019-12-20 |
2022-08-24 |
포세이다 테라퓨틱스, 인크. |
항-muc1 조성물 및 사용 방법
|
KR20220149588A
(ko)
|
2020-03-04 |
2022-11-08 |
포세이다 테라퓨틱스, 인크. |
대사성 간 장애의 치료를 위한 조성물 및 방법
|
EP4118107A1
(en)
|
2020-03-11 |
2023-01-18 |
Poseida Therapeutics, Inc. |
Chimeric stimulatory receptors and methods of use in t cell activation and differentiation
|
US20230190811A1
(en)
|
2020-04-14 |
2023-06-22 |
Poseida Therapeutics, Inc. |
Compositions and methods for use in the treatment of cancer
|
EP4231999A1
(en)
|
2020-10-21 |
2023-08-30 |
Poseida Therapeutics, Inc. |
Compositions and methods for delivery of nucleic acids
|
US20240060090A1
(en)
|
2021-02-23 |
2024-02-22 |
Poseida Therapeutics, Inc. |
Genetically modified induced pluripotent stem cells and methods of use thereof
|
EP4297728A1
(en)
|
2021-02-23 |
2024-01-03 |
Poseida Therapeutics, Inc. |
Compositions and methods for delivery of nucleic acids
|
EP4301863A1
(en)
|
2021-03-04 |
2024-01-10 |
Poseida Therapeutics, Inc. |
Compositions and methods for the treatment of hemophilia
|
IL305836A
(en)
|
2021-03-12 |
2023-11-01 |
Janssen Biotech Inc |
A method for treating psoriatic arthritis patients with insufficient response to TNF therapy with a specific anti-IL23 antibody
|
BR112023018353A2
(pt)
|
2021-03-12 |
2024-02-06 |
Janssen Biotech Inc |
Método seguro e eficaz para tratamento da artrite psoriática com anticorpo específico anti-il23
|
AU2022306973A1
(en)
|
2021-07-09 |
2024-02-22 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-il12/il23 antibody compositions
|
WO2023281462A1
(en)
|
2021-07-09 |
2023-01-12 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
CN117957251A
(zh)
|
2021-07-09 |
2024-04-30 |
詹森生物科技公司 |
用于制备抗tnf抗体组合物的制造方法
|
CA3234642A1
(en)
|
2021-10-04 |
2023-04-13 |
Poseida Therapeutics, Inc. |
Transposases and uses thereof
|
WO2023060088A1
(en)
|
2021-10-04 |
2023-04-13 |
Poseida Therapeutics, Inc. |
Transposon compositions and methods of use thereof
|
WO2023073615A1
(en)
|
2021-10-29 |
2023-05-04 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
US20230151087A1
(en)
|
2021-11-15 |
2023-05-18 |
Janssen Biotech, Inc. |
Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
|
WO2023095000A1
(en)
|
2021-11-23 |
2023-06-01 |
Janssen Biotech, Inc. |
Method of treating ulcerative colitis with anti-il23 specific antibody
|
WO2023141576A1
(en)
|
2022-01-21 |
2023-07-27 |
Poseida Therapeutics, Inc. |
Compositions and methods for delivery of nucleic acids
|
WO2023164573A1
(en)
|
2022-02-23 |
2023-08-31 |
Poseida Therapeutics, Inc. |
Genetically modified cells and methods of use thereof
|
US20230374122A1
(en)
|
2022-05-18 |
2023-11-23 |
Janssen Biotech, Inc. |
Method for Evaluating and Treating Psoriatic Arthritis with IL23 Antibody
|